GSE173123
Phytosterol accumulation results in ventricular arrhythmia, impaired cardiac function and death
Heart failure (HF) and cardiac arrhythmias share overlapping pathological mechanisms that act cooperatively to accelerate disease pathogenesis.  Cardiac fibrosis is associated with both pathological conditions.  Our previous work identified a link between phytosterol accumulation, cardiac fibrosis and death in a mouse model of phytosterolemia, a rare disorder characterized by elevated circulating phytosterols and increased cardiovascular disease risk.  Here, we uncover a previously unknown pathological link between phytosterols and cardiac arrhythmias in the same animal model.  Phytosterolemia resulted in inflammatory pathway induction, premature ventricular contractions (PVC) and ventricular tachycardia (VT).  Both pharmacological and genetic inhibition of phytosterol absorption prevented the induction of both pathways.  Inhibition of phytosterol absorption reduced inflammation and cardiac fibrosis, improved cardiac function, reduced the incidence of arrhythmias and increased survival in a mouse model of phytosterolemia.  Collectively, this work identified a pathological mechanism whereby elevated phytosterols result in inflammation and cardiac fibrosis leading to impaired cardiac function, arrhythmias and sudden death.  These phytosterolemia-associated comorbidities provide novel insight into the underlying pathophysiological mechanism that predispose these patients to increased risk of sudden cardiac death. Overall design: Heart tissue RNA-seq of vehicle- or Ezetimibe-treated of ABCG5/8 NPC1L1 TKO and ABCG5/8 male mice.